August 22, 2005
Clinical trials improving long odds of surviving lung cancerTopics: Medicine
Doctors already have improved the survival rate for patients diagnosed with advanced lung cancer in drug trials. Half of the patients participating in trials now live at least one year beyond diagnosis, compared to eight to 10 months for those not in trials.
The recent death of news anchor Peter Jennings from lung cancer served as a reminder that it remains the deadliest form of cancer. Each year, lung cancer claims more lives than breast, colon and prostate cancers combined.
Even young non-smokers are not immune, as illustrated by the recent announcement by Christopher Reeve's widow, Dana, 44, of her diagnosis with the disease. In fact, the number of non-smokers, particularly women, who develop lung cancer is on the rise.
While doctors don't yet understand the reasons for the increase, recent advances in clinical trials have given them new options for treating lung cancer.
Posted by Richard at August 22, 2005 10:11 PM
Articles Related to Medicine:
- Clinical trials improving long odds of surviving lung cancer - Aug 22, 2005